Agomelatine
Back to searchMolecule Structure
Scientific Name
Agomelatine
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06594
http://www.drugbank.ca/drugs/DB06594
Brand Name(s)
Valdoxan
Company Owner(s)
Not Available
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
Melatonin receptor | PROTEIN FAMILY | AGONIST | CHEMBL2094268 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL114476 |
PharmGKB | PA165958363 |
Human Metabolome Database | HMDB0015636 |
DrugBank | DB06594 |
PubChem: Thomson Pharma | 15121987 |
PubChem | 82148 |
Mcule | MCULE-3838308303 |
LINCS | LSM-45989 |
Nikkaji | J481.046E |
PDBe | AWY |
BindingDB | 50035179 |
EPA CompTox Dashboard | DTXSID3057642 |
DrugCentral | 99 |
ChemicalBook | CB8500647 |
Guide to Pharmacology | 198 |
PubChem: Drugs of the Future | 12014766 |
ChEBI | 134990 |
ZINC | ZINC000000005608 |